How much do paid clinical trials in Little Rock pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Little Rock?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Little Rock safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Little Rock, AR?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Little Rock typically complete one or two studies per year.

Paid Clinical Trials Little Rock, AR — 508 Studies Recruiting (Jul 2026)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Fibromyalgia Phase 3 Interventional 620 participants sought

Clinical Research Site — Little Rock, Arkansas (4.1 mi) · Sponsor: Axsome Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07398417)

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Iron Deficiency Anemia Phase 3 Interventional 75 participants sought

Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: AMAG Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT03893045)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought

University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Benign Prostatic Hyperplasia N/A Interventional 92 participants sought

Arkansas Urology — Little Rock, Arkansas (4.1 mi) · Sponsor: Urotronic Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06312722)

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought

Arkansas Urology — Little Rock, Arkansas (4.1 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07309445)

Comparison of Uncomplicated Candidemia Therapy Duration in Children

Invasive Candidiasis N/A Interventional 420 participants sought

Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: Arkansas Children's Hospital Research Institute

See eligibility & contact on ClinicalTrials.gov (NCT05763251)

Supervision in Substance Use Disorder Treatment Programs

Self Efficacy, Burnout, Professional N/A Interventional 43 participants sought

University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: University of Arkansas

See eligibility & contact on ClinicalTrials.gov (NCT07262372)

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis Phase 3 Interventional 400 participants sought

Baxis Site 04 — Little Rock, Arkansas (4.1 mi) · Sponsor: Baxis Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06911424)

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Hot Flashes, Breast Cancer Phase 2 Interventional 110 participants sought

Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: University of Arkansas

See eligibility & contact on ClinicalTrials.gov (NCT01530373)

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 2 Interventional 630 participants sought

Research Site — Little Rock, Arkansas (4.1 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT05061550)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 140 participants sought

Applied Research Center of Arkansas — Little Rock, Arkansas (4.1 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06598943)

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Asthma Phase 3 Interventional 231 participants sought

Research Site — Little Rock, Arkansas (4.1 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06023589)

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Schizophrenia Phase 3 Interventional 690 participants sought

Reviva site — Little Rock, Arkansas (4.1 mi) · Sponsor: Reviva Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT05184335)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought

University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05136196)

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 180 participants sought

Dermatology Trial Associates — Bryant, Arkansas (11.7 mi) · Sponsor: Organon and Co

See eligibility & contact on ClinicalTrials.gov (NCT07265479)

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary Angioedema, HAE Phase 3 Interventional 90 participants sought

ADARx Clinical Site — Little Rock, Arkansas (4.1 mi) · Sponsor: ADARx Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06960213)

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Infant, Intubation Complication N/A Interventional 3,000 participants sought

University of Arkansas Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: Children's Hospital of Philadelphia

See eligibility & contact on ClinicalTrials.gov (NCT05838690)

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Interventional 600 participants sought

CARTI Cancer Center — Little Rock, Arkansas (4.1 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06279013)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Respiratory Distress Syndrome, Pre-term Infants Phase 3 Interventional 520 participants sought

University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: Aerogen Pharma Limited

See eligibility & contact on ClinicalTrials.gov (NCT06776783)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought

University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06672146)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine Phase 3 Interventional 450 participants sought

Preferred Research Partners /ID# 249729 — Little Rock, Arkansas (4.1 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT05711394)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

CARTI Cancer Center — Little Rock, Arkansas (4.1 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia Phase 2 Interventional 186 participants sought

Medical Investigations Indications Inc. — Little Rock, Arkansas (4.1 mi) · Sponsor: Zucara Therapeutics Inc.

See eligibility & contact on ClinicalTrials.gov (NCT05762107)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought

University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Paid Clinical Trials in Little Rock, AR

Studies recruiting near Little Rock right now

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Comparison of Uncomplicated Candidemia Therapy Duration in Children

Supervision in Substance Use Disorder Treatment Programs

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Top-rated research centers in Little Rock

Baptist Health Center for Clinical Research

Applied Research Center and Wellness Clinic

Woodland International Research

Pillar Clinical Research, Little Rock, Arkansas

B.G. Clinical Research Center, LLC

Clinical Trials Inc

Lynn Institute of the Ozarks

Preferred Research Partners

Pillar Clinical Research

Clinical trials in Little Rock: what's recruiting

How to enroll in a paid study in Little Rock

Frequently asked questions

Paid clinical trials near Little Rock

More of AR

New paid studies open every week